The Antibody Society Meetings Committee,
2023 members
- Katherine Harris, Ph.D., Chief Development Officer, Rondo Therapeutics
- Jonathan Sockolosky, Ph.D., Director, Company Value Creation, Curie.Bio
- James A. Ernst, Ph.D., Senior Director, Head of Development Sciences, Xencor
- Jan Terje Andersen, Ph.D., Professor, University of Oslo and Group Leader Oslo University Hospital, Norway
- Jamie Spangler, Ph.D., Assistant Professor, Biomedical Engineering and Chemical & Biomolecular Engineering, Johns Hopkins University
- Stephen Beers, Ph.D., Professor of Immunology and Immunotherapy, Antibody and Vaccine Group, Centre for Cancer Immunology, University of Southampton, United Kingdom
- Mitchell Ho, Ph.D., Senior Investigator, Laboratory of Molecular Biology, NIH NCI
AE&T Europe 2023 Advisors
- Katherine Harris, Ph.D., Chief Development Officer, Rondo Therapeutics; Meetings Committee chair, The Antibody Society
- Sally Ward, Ph.D., Professor and Director, University of Southampton, United Kingdom; President, The Antibody Society
- Paul W.H.I. Parren, Ph.D., Professor, Department of Immunohematology and Blood Transfusion, Leiden University Medical Center and EVP and Head of R&D, Lava Therapeutics, The Netherlands; Board of Directors chair, The Antibody Society
- Kerry A. Chester, Ph.D., Professor of Molecular Medicine, UCL Cancer Institute, University College London, United Kingdom; Director, The Antibody Society
- Janine Schuurman, Ph.D., Vice President, The Antibody Society
- Andreas Plückthun, Ph.D., Professor and Director, Department of Biochemistry, University of Zürich, Switzerland; Member, The Antibody Society
- Sai Reddy, Ph.D., Associate Professor, Department of Biosystems Science and Engineering, ETH Zurich/Swiss Federal Institute of Technology, Switzerland
AE&T 2023 Guest Session Chairs
- Benjamí Oller-Salvia, Ph.D., Assistant Professor at IQS Barcelona, Ramon Llull University, Spain
- Rene Hoet, Ph.D., Chief Innovations Officer, FairJourney Biologics, Portugal; Member, The Antibody Society
- Dario Neri, Ph.D., CEO and CSO, Philogen, Switzerland; Member, The Antibody Society
- Stephen Beers, Ph.D., Professor of Immunology and Immunotherapy, Antibody and Vaccine Group, Centre for Cancer Immunology, University of Southampton, United Kingdom; Member, The Antibody Society
- Alain Beck, Ph.D., Senior Director, Biologics CMC and Developability, Pierre Fabre Group, France; Member, The Antibody Society
- Nicolas Fischer, Ph.D., CEO, Light Chain Bioscience, Switzerland; Member, The Antibody Society
- Marina Bacac, Ph.D., Head of Cancer Immunotherapy Department, Roche pRED, Switzerland
- Cédric R. Weber, Ph.D., Director of Data Science and Bioinformatics, Alloy Therapeutics, Inc., Switzerland; Member, The Antibody Society
- Jan Terje Andersen, Ph.D., Professor, University of Oslo and Group Leader Oslo University Hospital, Norway; Member, The Antibody Society
- Robert de Jong, Ph.D., Director Antibody Research & Technology, Genmab, The Netherlands; Member, The Antibody Society
- Ryan Fiehler, Ph.D., Associate Director, Discovery, F-star Biotechnology Ltd., United Kingdom
